Fundraising Fox
Parkwalk Advisors
Venture capitalLondon · Seed–Series C · 30 people tracked
Also known as Park Walk Advisors Ltd
Find your way into Parkwalk Advisors
Sign up to see every warm intro you have to Parkwalk Advisors
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Parkwalk Advisors team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Parkwalk invests in deeptech spinouts emerging from UK universities, aiming to convert pioneering academic research into commercially successful businesses. It bridges the funding gap between early academic discovery and later-stage venture capital, investing across the spinout lifecycle from seed to scale. As a leading EIS fund manager, Parkwalk offers investors tax-efficient opportunities while providing spinouts with funding, expertise, and networks. As part of IP Group plc, it supports companies from start-up to scale-up across core sectors including AI, quantum computing, hardware, cleantech, digital health, and life sciences, positioning itself as the UK's most active investor in university spinouts.
Source: firm website, verified Sep 27, 2026.
Team · 30 people
from the firm's website & curated & public directories
What they invest in
from 36 of 53 portfolio companiesMedical Devices ×15Deep Tech ×13Healthtech ×13AI & Machine Learning ×12Biotech ×10Hardware ×9Digital Health ×7Cleantech ×6
HQs:United Kingdom×26Brazil×1
Who they back
founder profiles across 9 portfolio companiesFounding team size:solo founder×42 founders×33 founders×14+ founders×1
Investments · 53 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 22024 · 62023 · 42022 · 52021 · 62020 · 12019 · 62018 · 22017 · 32016 · 12015 · 141 dated
52North Health develops NeutroCheck, a diagnostic tool that identifies neutropenia in chemotherapy patients presenting with fever, enabling risk stratification and reducing unnecessary emergency department visits.
BiotechDigital HealthHealthtechMedical DevicesCambridge, GB
Co-investorsMeridian Health VenturesCambridge Angels groupFuture Planet CapitalSie VenturesCambridge Innovation CapitalCrista Galli Ventures+2 more
8power builds 'Fit & Forget' wireless sensors that provide real-time condition monitoring, data and analytics for industrial machinery such as pumps, motors and gearboxes, allowing clients to track remote asset performance and plan maintenance.
Advanced ManufacturingAI & Machine LearningCleantechEnterprise SoftwareHardwareIoTCambridge, GB
Paul Egan(CEO)inGlen Clark(CEO)in
BoardRichard Green(Chairman)
Co-investorsCambridge Angels groupUniversity of Cambridge Enterprise
UK developer of 5G physical layer and channel coding IP for satellite non-terrestrial networks, spun out of the University of Southampton.
Co-investorsBloc VenturesIQ CapitalIP GroupSwisscom Ventures
.jpeg){kind=logo}
adsilico builds generative AI technology that creates diverse virtual patient populations—digital models of human anatomy, physiology, and pathology—to run in silico trials that assess medical device safety and performance before human testing.
AI & Machine LearningHealthtechMedical Devices
Dr Nishant RavikumarinDr Zeike TaylorinProf Alejandro FrangiSheena Macphersonin
Co-investorsNorthern Gritstone
Albus Health develops clinically validated monitoring technology that tracks respiratory metrics, heart rate, and cough frequency to support clinical studies.
BiotechDigital HealthHealthtechMedical Devices
Prof Maarten De Vos(Head of R&D)
Co-investorsCreative Destruction Lab (CDL)Meridian Health VenturesUCeed Funds
Alun is a Brazilian education group offering programs in technology, business, and artificial intelligence, spanning a tech-focused college, a digital products and business school, an executive development platform, and corporate training.
AI & Machine LearningEdTechFuture of Work
Co-investorsCrescera CapitalVulpes Investment Management
Aqdot is a supramolecular chemistry (chem-tech) company that develops proprietary AqFresh air quality and odour/VOC-elimination technology based on encapsulation.
CleantechDeep TechNew Materials
Dr Jing Zhang(Chief Executive Officer & Co-founder)Dr Roger Coulston(Chief Technical Officer & Co-founder)Hugh Rathbone(Chief Commercial Officer)inAlex Anikeeva(Chief Financial Officer)in
BoardTim Wright(Chairman)
Co-investorsProvidence Investment Company LimitedBusiness Growth FundIP GroupUniversity of Cambridge Enterprise
Arkivum provides a SaaS platform for long-term data archiving and preservation that ensures data remains secure, accessible, and readable for regulated organizations.
Data & InfrastructureEnterprise SoftwareSaaSReading, GB
Matthew [Last name not provided](CTO and Founder)
Co-investorsOxford
Arvia Technology provides water treatment solutions for removing organic compounds from wastewater across industrial applications including pharmaceutical manufacturing.
Advanced ManufacturingAgTechCleantechClimate TechEnterprise SoftwareRuncorn, GB
Dr. Nigel Brown(Founder)Dr. Ted Roberts
Disruptive hearing/audio clarity technology start-up
Co-investorsOctopus VenturesCambridge Innovation Capital
azulOptics develops eye-health screening technologies focused on prevention and early detection of eye disease.
HealthtechMedical DevicesBristol, GB
Shelby Temple(CEO, Co-founder)inMatt Evans(COO, Co-founder)in
Clean alternative to fluid refrigerants using barocaloric effect
Cambridge, GB
Xavier Moya(CEO / Founder)in
Co-investorsWorld FundIP Group
.svg)
BibliU is a digital learning platform that partners with publishers to provide students affordable, instant access to course content, and offers institutions workflow automation to reduce administrative burden.
EdTechSaaS
Dave Sherwood(CEO & Co-Founder)in
.avif)
Co-investorsBrick Capital VenturesGreen Shores CapitalGuinness VenturesKreos CapitalOxford Science EnterprisesBeyond Ventures+4 more
Bitfount provides a federated learning and data science platform that enables organizations to run AI models, conduct analytics, and perform model training on private data without transferring it to third parties.
AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtechLondon, GB
Co-investorsPace VenturesSpeedinvestAhren Innovation CapitalForesight GroupPortfolio Ventures
Brainomix, a spin-out from the University of Oxford, develops AI-powered imaging biomarkers and software that help physicians interpret medical images to support clinical decisions.
AI & Machine LearningDigital HealthMedical DevicesOxford, GB
Michalis Papadakis(CEO)inAlastair Buchan(Co-founder; Oxford Professor of Stroke Medicine)
Co-investorsModi VenturesBoehringer Ingelheim Venture Fund
Cambridge GaN Devices is a fabless semiconductor company that develops energy-efficient GaN-based power devices for sustainable electronics.
CleantechDeep TechEnergyHardwareSemiconductorsCambridge, GB
Fabio Necco(CEO)in
Co-investorsCambridge Innovation CapitalEMV CapitalIQ CapitalMartlet CapitalBritish Patient CapitalBusiness Growth Fund+1 more
Ceryx Medical develops medical device technology, presenting a leadership and research team alongside its publications.
BiotechHealthtechMedical Devices
Julian Paton(Founder)inStuart Plant(CEO)inMalcolm Hamer(CTO)inBrenig Preest(CFO)in
BoardChas Taylor(Chairman)in
Co-investorsOutset Ventures
Charco Neurotech develops the CUE1, a non-invasive device that uses vibratory stimulation to ease movement symptoms and improve quality of life for people with Parkinson's disease.
Digital HealthHardwareHealthtechMedical Devices
Co-investorsAmadeus Capital PartnersCambridge Angels groupNew Wave VenturesUTECCrista Galli Ventures
Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB
Co-investorsCambridge Innovation CapitalFuture Planet CapitalQVenturesXeraya CapitalAmadeus Capital PartnersIDO Investments+3 more
Crypto Quantique designs low-footprint security IP and lifecycle software for system-on-chip (SoC), chiplets, and connected IoT devices, ensuring device identity and integrity are anchored in silicon.
CybersecurityHardwareIoTSemiconductorsLondon, GB
Shahram Mossayebi(CEO & Co-Founder)inPatrick Camilleri(Co-Founder)in
Co-investorsEntrepreneur FirstKima VenturesAccelerated Digital VenturesAcequia Capital (AceCap)ADVAlma Angels+2 more
Cytora provides AI-powered risk processing software for commercial insurance carriers and brokers to automate underwriting, claims decisions, and portfolio management.
AI & Machine LearningEnterprise SoftwareInsurTech
Richard Hartley(Founder)inAeneas Wiener(Founder)inAndre Alzamora(Founder)Joshua Wallace(Founder)
Co-investorsEQT VenturesCambridge Innovation CapitalClaret Capital PartnersQBE Ventures
Hone Bio is a pre-clinical biotech company developing NanoPilot lipid nanoparticle (LNP) targeting technology for extrahepatic drug delivery, engineering LNPs to target specific cell types while blocking off-target liver uptake.
BiotechDeep TechBristol, GB
Co-investorsFuture Planet Capital
Echopoint Medical develops cardiac technology focused on coronary physiology for interventional cardiology.
Deep TechHardwareHealthtechMedical DevicesLondon, GB
Antony Odell(CEO & co-Founder)inMalcolm Finlay(CMO & Co-founder)inAdrien Desjardins(CSO & Co-Founder)inPriscila Hancock(Executive Officer)Nijs van de Vaart(COO)inPri Hancock(CFO)in
Co-investorsUCL Technology FundQueen Mary University of LondonAlbionVCNew Wave Ventures
Entia develops at-home blood monitoring solutions for healthcare providers and patients.
Digital HealthHealthtechMedical Devices
Dr Toby Basey-Fisher(CEO & Founder)
Co-investorsOxford Technology ManagementSussex Place Ventures
TextMine automates data extraction from business-critical documents using AI, serving enterprises in financial services, legal, and technology sectors that require high accuracy and security in document processing workflows.
AI & Machine LearningFintechLegalTechSaaSLondon, GB
Charles BrecqueinMary Catherine Di Nunzio(CLO)inMary Catherine(Chief Legal Officer)
Co-investorsOxfordPerivoli Innovations
Mind Foundry develops deployed AI and machine learning systems for high-risk, high-complexity operational domains, including defense applications such as multi-sensor data fusion for battlespace situational awareness and threat-signature analysis.
AI & Machine LearningDeep TechDefense Tech
Stephen Roberts(Co-founder)inMichael Osborne(Co-founder)
Co-investorsOxford Science Enterprises
Mogrify is a biotechnology company developing in vivo cellular reprogramming therapies, using its proprietary MOGRIFY and epiMOGRIFY platforms that apply transcriptomic and epigenetic data to identify transcription factor combinations for converting one cell type into another.
BiotechDeep TechHealthtech
Julian Gough(Co-founder)inOwen Rackham(Co-founder)inJose Polo(Co-founder)inDarrin M. Disley(CEO)in
BoardJane Osbourn(Chair)
Co-investorsAhren Innovation CapitalAstellas Venture Management LLC
Opsydia develops optical and photonic technologies for precision manufacturing, emerging from research in adaptive optics and laser processing at the University of Oxford.
Advanced ManufacturingAI & Machine LearningDeep TechHardwareNew MaterialsSemiconductorsOxford, GB
Martin Booth(Founder and Director)inPatrick Salter(Founder and Director)inDr. Noel Moore(Chief Technology Officer)
BoardNigel Vaughan(Chairman)
Co-investorsOxford Science EnterprisesForesight GroupOxford University Innovation
Paragraf develops graphene-based electronic devices, including molecular sensors (electrolyte-gated field-effect transistors) for biosensing and chemical sensing, and Hall effect sensors for current, position, and magnetic field measurement at cryogenic temperatures.
Deep TechNew MaterialsSemiconductorsCambridgeshire, GB
Simon Thomas(Chief Executive Officer of the issuer.)in
Co-investorsAmadeus Capital PartnersBlack Opal VenturesCambridge Angels groupEMV CapitalIn-Q-TelIQ Capital+5 more
Pathfinder Med develops its patented ePATH catheter guidance platform for endovascular procedures in peripheral interventions and vascular access creation.
HardwareHealthtechMedical DevicesLondon, GB
Dr. Lorenzo Patrone(Chief Medical Officer)
Co-investorsCambridge Angels groupDeepbridge Capital
Novel antibody-based therapeutics platform for animal health.
Co-investorsCambridge Innovation CapitalCompanion FundDigitalis VenturesVCapital
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesDiamond Edge VenturesO2h VenturesWren Capital
Phasecraft develops quantum computing systems and software by combining quantum information theory, materials science, and engineering to advance practical quantum advantage.
AI & Machine LearningDeep TechQuantum Computing
Prof. Ashley Montanaro(Co-Founder & CEO)inProf. Toby Cubitt(Co-Founder, CTO & CSciO)inProf. John Morton(Co-Founder & Director)inAshley Montanaro(Founder)John Morton(Founder)Toby Cubitt(Founder)
Co-investorsAlbionVCEpisode1LocalGlobePlayground GlobalUCL Technology FundLondon Co-Investment Fund+1 more
PhoreMost is a biotechnology company developing small molecule drugs and targeted protein degradation therapeutics for cancers with high unmet clinical need, with a lead program (PMC-001) for primary and metastatic brain cancers in Phase 1/2a clinical evaluation.
BiotechMedical DevicesCambridge, GB
Co-investorsAmadeus Capital PartnersAstellas Venture Management LLCCambridge Angels groupUniversity of Cambridge EnterpriseAmadeus Capital SAO2h Ventures
Proxisense develops high-performance sensors for monitoring manufacturing processes and diagnostics, with origins in aerospace and defence applications.
Advanced ManufacturingDeep TechHardwareIoTMedical DevicesOxford, GB
Paul Vickery(Founder and Chairman)Kam Chana(Founder and NED)
Co-investorsFuture Planet CapitalOxford Science Enterprises
Quantum Motion develops utility-scale quantum computers using silicon spin-qubit architecture compatible with standard semiconductor manufacturing processes and existing foundry supply chains.
Deep TechQuantum ComputingSemiconductors
Co-investorsBosch VenturesDCVC (Data Collective)InkefOctopus VenturesOxford Science EnterprisesSony Ventures Corporation+2 more
Semarion is a University of Cambridge spin-out developing the SemaCyte platform, which converts adherent cells into barcoded, ready-to-use reagents for accelerated drug discovery and cell-based research.
BiotechDeep TechMedical DevicesNew MaterialsSaaSCambridge, GB
Jeroen Verheyen(CEO and Co-Founder)inTarun Vemulkar(Co-founder & CTO)in
Co-investorsThe FSE GroupCambridge Capital GroupFound CapitalStart CodonEMV CapitalMartlet Capital
xWatts is an intelligent energy management platform that connects to building energy systems, models facilities in real time, and automatically optimizes assets like HVAC, solar, and CHP engines to reduce energy costs and emissions in large, complex estates and industrial facilities.
CleantechClimate TechEnergyEnterprise SoftwarePropTech
Yigit Akar(Co-founder & CEO)inAlex Allen(Co-founder & CPO)Alexander A.(Founder)in
Co-investorsAntlerR42 GroupCambridge Angels groupPlug and Play Ventures
YASA designs and manufactures axial-flux electric motors for automotive OEM customers such as Ferrari and Lamborghini, operating an axial-flux factory in Oxfordshire, UK.
Advanced ManufacturingCleantechHardwareMobility & TransportationOxford, GB
Tim Woolmer(Founder & CTO)inJörg Miska(Chief Executive Officer)
Co-investors24 HaymarketOxford Science EnterprisesInovia Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
1715 LabsACAL EnergyAnimal DynamicsArviaBramble EnergyEnhanc3D GenomicsHynt Labs LimitedIkarovecMirriadMoa TechnologyOxford EndovascularPredictImmuneTextMine
Exits · 4
4 acquisitions · showing 2Portfolio news
latest coverage across their companiesBibli U · finsmes.com · Jun 3, 2026
Barocal · eu-startups.com · May 4, 2026
Brainomix · prnewswire.com · Feb 24, 2026
xWatts · thesaasnews.com · Feb 10, 2026
Opsydia · opsydia.com · Jul 30, 2025
Bitfount · eu-startups.com · Jul 23, 2025
Ceryx Medical · ceryxmedical.com · Jun 20, 2025
Principals & officers · per Companies House
what is this? ⓘDirector · British · since 2015
Director · British · since 2024
Director · British · since 2021
Director · British · since 2022
Director · British · since 2009
Ip Group Plc — 75–100% of shares
Frequently asked questions
- How many investments has Parkwalk Advisors made?
- Parkwalk Advisors has 53 tracked investments, 4 of which have exited, including 4 dated in the last 24 months.
- What stage does Parkwalk Advisors invest at?
- Parkwalk Advisors invests at the Seed, Series A, Series B, Series C stages.
- What sectors does Parkwalk Advisors focus on?
- Parkwalk Advisors focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Digital Health, Hardware, Healthtech, IoT, Medical Devices, Quantum Computing, SaaS.
- Where is Parkwalk Advisors located?
- Parkwalk Advisors is headquartered in London, GB.
- Does Parkwalk Advisors lead rounds?
- Parkwalk Advisors typically participates in rounds rather than leading them.
- Who does Parkwalk Advisors co-invest with?
- Parkwalk Advisors most often shares deals with Oxford Science Enterprises, Cambridge Angels group, Cambridge Innovation Capital, among 26 tracked co-investors.
Images
Co-investors · 16
Oxford Science Enterprises builds and funds companies founded on science and research from the University of Oxford, targeting deep tech, life sciences and healthtech.
Cambridge Innovation Capital (CIC) is a UK-based venture capital firm backing entrepreneurs in life sciences and deep tech, leveraging its position in the Cambridge science and technology ecosystem.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Future Planet Capital is a UK-founded, impact-led venture capital firm that invests in high-growth companies benchmarked against the world's top universities and centres of innovation, with a global portfolio mapped to the UN Sustainable Development Goals.
AlbionVC is an early-stage venture capital firm backing European founders, providing both capital and operational expertise across deeptech, health, finance, and intelligence sectors.
BGF is a UK and Ireland investor providing minority, patient growth capital and support to entrepreneurial small and medium-sized businesses, from early-stage deep tech and life sciences startups to established scaling companies.
Astellas Venture Management (AVM) is the wholly-owned corporate venture arm of Astellas, providing equity investments to private, early-stage biotechnology companies developing therapeutic programs and platform technologies for drug discovery.
LocalGlobe is part of a multi-generational Phoenix Court platform that backs companies from pre-seed through public markets, founded by the Klein family who are considered founders of European seed investing with multi-decade relationships across the European tech ecosystem. The fund operates from a physical founder village at Phoenix Court in London and focuses on backing unconventional entrepreneurs in specific geographic neighbourhoods, having been among the earliest institutional backers of European outliers like Wise, Zoopla, and Citymapper.
Playground Global is a venture capital firm that invests in deep tech companies built by scientists and engineers, spanning next-generation compute, automation, energy, and computational biology.
Digitalis Ventures invests in solutions to unmet needs in biomedicine and health, backing biotechnology and technology-enabled companies across human health and animal health.
ePlanet Capital invests in growth-stage companies across global markets. The firm targets companies positioned as leaders in their respective sectors.
Bioqube Ventures is a global life sciences investment firm with offices in Belgium and the United States, focused on turning scientific discoveries into transformative medicines.
▶4 more co-investors
Firms observed investing alongside Parkwalk Advisors, from public investor directories. Shared companies are the overlap with Parkwalk Advisors's recorded portfolio.
Similar investors
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Robert Bosch Venture Capital GmbH (Bosch Ventures) is the corporate venture capital arm of Robert Bosch, headquartered in Stuttgart, Germany, with offices across Europe, the US, Israel, and China.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.
BDC (Business Development Bank of Canada) is a Canadian financial institution that has supported small and medium-sized businesses across all industries and stages of growth for over 80 years, providing financing and advisory services.